Literature DB >> 15396069

Chloramphenicol in the treatment of infectious diseases.

J E SMADEL.   

Abstract

Entities:  

Keywords:  CHLORAMPHENICOL; COMMUNICABLE DISEASES

Mesh：

Substances：

Year:  1949        PMID： 15396069     DOI： 10.1016/0002-9343(49)90389-7

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  9 in total

1.  Some recent advances and current problems in the field of rickettsial diseases.

Authors:  H R COX
Journal:  Arch Gesamte Virusforsch       Date:  1951

2.  Infantile gastro-enteritis with special reference to the specific serological type O55 B5 H6 (Beta type) of Bacterium coli.

Authors:  J Smith; W H Galloway; A L Speirs
Journal:  J Hyg (Lond)       Date:  1950-12

3.  [Mechanism of effect of aureomycin and chloromycetin in therapy of rickettsial and typhoid diseases].

Authors:  F O HORING
Journal:  Klin Wochenschr       Date:  1951-01-15

4.  Therapeutic results with aureomycin and chloramphenicol.

Authors:  T E WOODWARD; R T PARKER; H E HALL
Journal:  Bull N Y Acad Med       Date:  1950-01

5.  Fatal aplastic anaemia after chloramphenicol treatment.

Authors:  L A HAWKINS; H LEDERER
Journal:  Br Med J       Date:  1952-08-23

6.  Fatal aplastic anaemia after chloramphenicol.

Authors:  B WOLMAN
Journal:  Br Med J       Date:  1952-08-23

7.  Fatal aplastic anemia following chloramphenicol (chloromycetin) therapy.

Authors:  C WINTERNITZ
Journal:  Calif Med       Date:  1952-11

8.  Treatment of the typhoid carrier state with chloramphenicol.

Authors:  T T CROCKER; A GELPERIN
Journal:  Yale J Biol Med       Date:  1950-11

9.  Streptomyces venezuelae NRRL B-65442: genome sequence of a model strain used to study morphological differentiation in filamentous actinobacteria.

Authors:  Juan Pablo Gomez-Escribano; Neil A Holmes; Susan Schlimpert; Maureen J Bibb; Govind Chandra; Barrie Wilkinson; Mark J Buttner; Mervyn J Bibb
Journal:  J Ind Microbiol Biotechnol       Date:  2021-12-23       Impact factor: 4.258
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.